Chronic cutaneous sclerodermoid graft-versus-host disease: Evaluation by 20-MHz sonography

Journal of the European Academy of Dermatology and Venereology

Volumn 17, Issue 4, 2003, Pages 402-407

  Gottlöber, Petra ^a   Leiter, U ^a   Friedrich, W ^a   Bunjes, D ^a   Schulz, A ^a   Kerscher, M ^a   Peter, R U ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Cutaneous graft versus host disease; Diagnosis; Skin; Sonography

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; B SCAN; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMIS; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ECHOGRAPHY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LICHENOID; MALE; NON INVASIVE MEASUREMENT; PATIENT MONITORING; PHOTOTHERAPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REMISSION; SCHOOL CHILD; SCLERODERMA; SKIN DISEASE; SKIN FIBROSIS; SKINFOLD THICKNESS; SUBCUTANEOUS TISSUE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BIOPSY, NEEDLE; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC DISEASE; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PUVA THERAPY; RISK ASSESSMENT; SAMPLING STUDIES; SCLERODERMA, LOCALIZED; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0038267372     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2003.00516.x     Document Type: Article

References (20)

1. Aubin F, Brion A, Deconick E. Phototherapy in the treatment of cutaneous graft versus host disease. Transplantation 1995; 59: 151-155.
2. Ferrara JLM, Deeg HKJ. Graft versus host disease. N Engl J Med 1991; 324: 667-674.
3. Jampel RM, Farmer EV, Vogelsang GB et al. PUVA-therapy for chronic cutaneous graft-vs-host disease. Arch Dermatol 1991; 127: 1673-1678.
4. Volc-Platzer B, Hönigsmann H, Hinterberger W, Wolff K. Photochemotherapy improves chronic cutaneous graft-versus-host disease. J Am Acad Dermatol 1990; 50: 220-228.
5. Saurat JH. Cutaneous manifestations of graft versus host disease. Int J Dermatol 1981; 20: 249-256.
6. Tanaka K, Sullivan KM, Shulman HM. A clinical review: cutaneous manifestations of acute and chronic graft-versus-host-disease following bone marrow transplantation. J Dermatol 1991; 18: 11-17.
7. Elder D. Lever's Histopathology of the Skin. Lippincott-Raven, Philadelphia, 1997.
8. Spielvogel RL, Goltz RW, Kersey JH. Scleroderma-like changes in chronic graft vs host disease. Arch Dermatol 1977; 113: 1424-1428.
9. Hoffmann K, Gerbaulet U, el-Gammal S, Altmeyer P. 20-MHz B-mode ultrasound in monitoring the course of localized scleroderma. Acta Derm Venereol 1991; 164: 3-16.
10. Altmeyer P, el-Gammal S, Hoffmann K. Ultrasound in Dermatology. Springer-Verlag, Berlin, 1992.
11. Eisenbeiss C, Welzel J, Schmeller W. The influence of female sex hormones on the skin thickness: evaluation using 20 MHz sonography. Br J Dermatol 1998; 139: 462-467.
12. Gniadecka M, Gniadecka R, Serup J, Sondergaard J. Ultrasound structure and digital image analysis of the subepidermal low echogenic band in aged human skin: diurnal changes and interindividual variability. J Invest Dermatol 1994; 102: 362-365.
13. Gniadecka M, Jemec GBE. Quantitative evaluation of chronological ageing and photoageing in vivo: studies on skin echogenicity and thickness. Br J Dermatol 1998; 139: 815-821.
14. Gottlöber P, Kerscher M, Korting HC, Peter RU. Sonographic determination of cutaneous and subcutaneous fibrosis after accidential exposure to ionizing radiation in the course of the Chernobyl nuclear power plant accident. Ultrasound Med Biol 1997; 23: 9-13.
15. Grundmann-Kollmann M, Behrens S, Gruss C et al. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA 1 phototherapy. J Am Acad Dermatol 2000; 42: 134-136.
16. Harland CC, Bamber JC, Gusterson BA, Mortimer PS. High frequency, high resolution B-scan ultrasound in the assessment of skin tumours. Br J Dermatol 1993; 128: 525-532.
17. Kerscher MJ, Korting HC. Assessment of the atrophogenicity potential of chemically different potent topical glucocorticoids by high frequency ultrasound. Eur J Dermatol 1992; 2: 440-442.
18. Krähn G, Gottlöber P, Sander C, Peter RU. Dermatoscopy and high frequency sonography: two useful non-invasive methods to increase preoperative diagnostic accuracy in pigmented skin lesions. Pigment Cell Res 1998; 11: 151-154.
19. Peter RU, Gottlöber P, Nadejina N et al. Interferon gamma in survivors of the Chernobyl power plant accident - new therapeutic option for radiation induced fibrosis. Int J Radiat Oncol Biol Phys 1999; 45: 147-152.
20. Leiter U, Kaskel P, Krähn G, Gottlober P et al. Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease. Photochemical Photoimmunol Photomed 2002; 18: 183-190.